Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Asymmetric synthesis of 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI)

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

related to degree

  • Lajiness, James, Ph.D. in Organic Chemistry, Scripps Research 2007 - 2012

authors

  • Lajiness, James
  • Boger, Dale

publication date

  • 2011

journal

  • Journal of Organic Chemistry  Journal

abstract

  • A short, asymmetric synthesis of the 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI) analogue of the CC-1065 and duocarmycin DNA alkylation subunits is described. Treatment of iodo-epoxide 5, prepared by late-stage alkylation of 4 with (S)-glycidal-3-nosylate, with EtMgBr at room temperature directly provides the optically pure alcohol 6 in 87% yield (99% ee) derived from selective metal-halogen exchange and subsequent regioselective intramolecular 6-endo-tet cyclization. The use of MeMgBr or i-PrMgBr also provides the product in high yields (82-87%), but requires larger amounts of the Grignard reagent to effect metal-halogen exchange and cyclization. Direct transannular spirocyclization of 7 following O-debenzylation of 6 provides N-Boc-CBI. This approach represents the most efficient (9-steps, 31% overall) and effective (99% ee) route to the optically pure CBI alkylation subunit yet described.

subject areas

  • Alkylation
  • Crystallography, X-Ray
  • Cyclization
  • Cyclopropanes
  • Halogens
  • Indicators and Reagents
  • Indoles
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
scroll to property group menus

Identity

PubMed Central ID

  • PMC3079324

International Standard Serial Number (ISSN)

  • 0022-3263

Digital Object Identifier (DOI)

  • 10.1021/jo102136w

PubMed ID

  • 21192653
scroll to property group menus

Additional Document Info

start page

  • 583

end page

  • 587

volume

  • 76

issue

  • 2

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support